Key result
Erectile dysfunction and cavernous artery abnormalities are linked to ~3-fold higher major cardiovascular events risk.
Why the study?
This scoping review sought to synthesize original human and animal studies on erectile dysfunction as a cardiovascular risk marker, predictor, mechanistic phenotype, screening opportunity, and treatment-relevant condition.
Answers are grounded in this paper and cite their sources.
Erectile dysfunction acts as a vascular sentinel for systemic cardiovascular disease and MACE, supporting its use as an actionable trigger for cardiovascular risk assessment and integrated urology-cardiology care.
To synthesize original human and animal studies relevant to “cardiovascular erectile dysfunction,” with emphasis on ED as a cardiovascular risk marker, predictor, mechanistic phenotype, screening opportunity, and treatment-relevant clinical condition. The review uses 211 references and builds its evidence map from 886 original studies with 53214933 total participants/sample observations (topic-deduplicated ΣN). The dominant signal across this scoping review is that erectile dysfunction behaves as a vascular sentinel of systemic cardiovascular disease, with ED severity tracking future events, mortality, and subclinical vascular abnormalities rather than representing an isolated urological condition. This pattern recurs across endothelial, arterial-stiffness, coronary-flow, and imaging-based studies, and is reinforced by penile Doppler findings linking cavernous artery abnormalities to roughly threefold higher MACE risk. PDE5 inhibitors appear generally tolerated in stable cardiovascular settings, although nitrate co-use remains a clinically critical safety boundary. Taken together, the evidence supports treating ED as an actionable trigger for cardiovascular risk assessment and integrated urology–cardiology care, while recognizing that mapped associations do not establish causality. Future prospective trials should test whether ED-initiated cardiovascular screening pathways measurably reduce events compared with usual care.
No takes yet. Share an insight, caveat, or question.
SAIMSARA (2026) conducted a review in Erectile dysfunction and cardiovascular disease (n=53,214,933). Erectile dysfunction / cavernous artery abnormalities was evaluated on Major adverse cardiovascular events (MACE), future cardiovascular events, mortality, and subclinical vascular abnormalities. Erectile dysfunction and penile Doppler cavernous artery abnormalities were associated with a roughly 3-fold higher risk of major cardiovascular events across 886 studies.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: